← Open Payments lookup

LAURA PONTES: Open Payments

NPI 1770706343 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,966 in 72 payments from 11 companies in 2025. Trend: 2023 $1,683 · 2024 $12,121 · 2025 $5,966

Consulting: $3,450Food & beverage: $1,991Travel & lodging: $467Education: $58
CompanyPaymentsAmount
Lilly USA, LLC8$2,898
Janssen Biotech, Inc.12$1,570
ABBVIE INC.29$682
Takeda Pharmaceuticals U.S.A., Inc.14$305
PFIZER INC.2$216
Janssen Scientific Affairs, LLC1$141
Ardelyx, Inc.2$54
Madrigal Pharmaceuticals1$28
Regeneron Healthcare Solutions, Inc.1$26
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23

Products named: OMVOH, TREMFYA, SKYRIZI, ENTYVIO, VELSIPITY, RINVOQ, CREON, IBSRELA.

Industry payments across TX — which companies pay providers there.